NL-OMON41063
Not yet recruiting
Not Applicable
Assessing fetal hemoglobin in patients on Tranylcypromine - TCP-HbF
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hereditary anemia
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients who give consent, taking Tranylcypromine for 2 months or longer, prescribed by their attending physician as part of their regular treatment.
Exclusion Criteria
- •Non\-compliance; hemophobia.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Clinical Trial to study the incidence of hemoglobinopathies in antenatal women lessthan 20 weeks attending tertiary care centreCTRI/2023/01/048851Jawaharlal Nehru Medical College
Completed
Not Applicable
Prenatal and neonatal screening of haemoglobinopathies: a prospective studyHaemoglobinopathiesHaematological DisordersOther hereditary haemolytic anaemiasISRCTN88941850HagaZiekenhuis (The Netherlands)2,000
Completed
Not Applicable
Antenatal screening for haemoglobinopathies in primary care: a cluster randomised trial to inform a simulation modelISRCTN00677850Department of Health (UK)1,320
Not yet recruiting
Not Applicable
The levels of HbA1c (which represents the sugar level in the past 3 months) in first 3 months of pregnancy and the pregnancy outcomesCTRI/2020/04/024544Dr Sai Snehitha V
Completed
Not Applicable
Non-invasive Measurement of Hemoglobin in Infants and NeonatesHemoglobinsNCT02655107University Hospital Schleswig-Holstein60